[조사자료] 세계의 플라스미드 DNA 제조 시장 2024-2030 : 질환별 (암, 감염), 등급별 (R&D 등급, GMP 등급), 용도별, 개발 단계별, 지역별

■ 영문 제목 : Plasmid DNA Manufacturing Market Size, Share & Trends Analysis Report By Disease (Cancer, Infectious Diseases), By Grade (R&D Grade, GMP Grade), By Application, By Development Phase, By Region, And Segment Forecasts, 2024 - 2030
	■ 상품코드 : GRV24JAN052 ■ 조사/발행회사 : Grand View Research ■ 발행일 : 2023년 11월 ■ 페이지수 : 110 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (납기 : 3일) ■ 조사대상 지역 : 세계 ■ 산업 분야 : 바이오

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD5,950 ⇒환산￦8,330,000	견적의뢰/주문/질문
Multi User (5인 열람용)	USD6,950 ⇒환산￦9,730,000	견적의뢰/주문/질문
Global/corporate License (기업 열람용)	USD8,950 ⇒환산￦12,530,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

글로벌 플라스미드 DNA 제조 시장의 성장과 동향
Grand View Research, Inc.사의 최신 보고서에 따르면, 세계의 플라스미드 DNA 제조 시장 규모는 2024년부터 2030년까지 연평균 21.01% 성장하여 2030년에는 67억 달러에 달할 것으로 예상됩니다. 만성 질환의 유병률 증가와 의료 산업에서 플라스미드 DNA의 광범위한 응용 범위가 결합하여 산업 성장을 촉진할 것으로 예상됩니다. 플라스미드 DNA는 백신 항원 생산 및 유전자 치료와 같은 치료 용도에 직접적으로 사용될 수 있습니다. 또한 유전자 복제, 유전자 매핑 등 다양한 연구 목적으로도 사용할 수 있습니다. 유전자 치료를 선택하는 환자 수가 증가함에 따라 향후 몇 년 동안 업계의 성장을 촉진할 것으로 예상됩니다.

clinicaltrials.gov에 따르면, 전 세계 파이프라인 프로그램(임상 1상부터 임상 3상까지) 전체 세포 및 유전자 치료제의 수는 2018년 289개에서 2022년 327개로 증가할 것으로 예상됩니다. 또한, 미국 FDA는 제품 제조와 관련된 여러 정책을 통해 첨단 치료 분야의 혁신을 지속적으로 지원하고 있습니다. 세포 및 유전자 치료 제품이 증가함에 따라 업계는 플라스미드 DNA를 대규모로 생산해야 할 필요성이 증가할 것이며, 코로나19의 팬데믹은 업계 성장에 긍정적인 영향을 미칠 것으로 예상됩니다. 예를 들어, 2021년 9월 인도는 최초의 코로나19 DNA 백신을 승인했습니다. 이는 Mission COVID Suraksha의 일환으로 DBT-BIRAC과 협력하여 생산된 세계 최초의 코로나19 DNA 백신입니다.

원형 DNA는 인도의 ZyCoV-D 백신 접종에 사용되어 코로나19 감염을 예방합니다. 또한, 글로벌 업계 주요 기업들은 시장 입지를 강화하기 위해 다양한 전략적 노력을 기울이고 있으며, 이 또한 성장을 촉진할 것으로 예상됩니다. 예를 들어, 2022년 6월 바이오시나는 CDMO 서비스 제공을 위해 새로운 전용 GMP 스위트에서 플라스미드 DNA 생산을 확대한다고 발표했습니다. 이 스위트는 최대 300L의 일회용 발효 용량과 적절한 규모의 다운스트림 처리 기계를 갖추고 있습니다.

플라스미드 DNA 제조 시장 보고서 주요 내용

- 2023년 GMP 등급 유형이 가장 큰 매출 점유율을 차지했으며, GMP 등급 플라스미드 DNA는 생체 내 분포 및 독성 테스트를 포함한 유전자 치료 및 백신 접종에 대한 전임상 시험에 널리 사용되고 있습니다.

- 유전자 백신 접종에서 임상 연구용 플라스미드 DNA의 중요성이 높아짐에 따라 2023년에는 임상 치료 분야가 전 세계 산업을 주도할 것으로 예상됩니다.

- 유전성 질환 및 유전성 장애 치료에 대한 유전자 치료에 대한 높은 수요로 인해 2023년에는 세포 및 유전자 치료 분야가 업계를 주도했습니다.

- 북미는 의료 인프라 개선, 높은 가처분 소득, 첨단 치료제 연구개발에 종사하는 센터 및 연구기관의 수, 첨단 치료제 채택 증가로 인해 2023년 지역별로 시장 규모를 주도했습니다.

- 아시아 태평양 지역은 이 분야의 활발한 R&D 활동과 주요 플레이어의 존재로 인해 예측 기간 동안 가장 빠른 CAGR을 기록할 것으로 예상되고 있습니다.

■ 보고서 개요

1. 조사 방법 및 범위
2. 개요
3. 세계의 플라스미드 DNA 제조 시장 변수/동향/범위
4. 세계의 플라스미드 DNA 제조 시장 규모 : 등급별 비즈니스 분석
5. 세계의 플라스미드 DNA 제조 시장 규모 : 개발 단계별 비즈니스 분석
6. 세계의 플라스미드 DNA 제조 시장 규모 : 용도별 비즈니스 분석
7. 세계의 플라스미드 DNA 제조 시장 규모 : 질병별 비즈니스 분석
8. 세계의 플라스미드 DNA 제조 시장 규모 : 지역별 비즈니스 분석
9. 경쟁 현황

■ 보고서 목차

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Information analysis
1.2.2. Market formulation & data visualization
1.2.3. Data validation & publishing
1.3. Information Procurement
1.3.1. Primary Others
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Market Model
1.7. Objectives
1.7.1. Objective 1
1.7.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Increasing number of patients opting for gene therapy
3.3.2. Robust pipeline for gene therapies
3.3.3. Highly competitive market and various strategies undertaken by market players
3.3.4. Increasing demand for plasmid DNA in various medical therapies
3.4. Market Restraint Analysis
3.4.1. Regulatory, Scientific, And Ethical Challenges Associated With Gene Therapy
3.5. Business Environment Analysis
3.5.1. PESTEL Analysis
3.5.2. Porter’s Five Forces Analysis
3.5.3. COVID-19 Impact Analysis
Chapter 4. Grade Business Analysis
4.1. Global Plasmid DNA Manufacturing Market: Grade Movement Analysis
4.2. R&D Grade
4.2.1. R&D Grade Market, 2018 – 2030 (USD Million)
4.3. GMP Grade
4.3.1. GMP Grade Market, 2018 – 2030 (USD Million)
Chapter 5. Development Phase Business Analysis
5.1. Global Plasmid DNA Manufacturing Market: Development Phase Movement Analysis
5.2. Pre-Clinical Therapeutics
5.2.1. Pre-Clinical Therapeutics Market, 2018 – 2030 (USD Million)
5.3. Clinical Therapeutics
5.3.1. Clinical Therapeutics Market, 2018 – 2030 (USD Million)
5.4. Marketed Therapeutics
5.4.1. Marketed Therapeutics Market, 2018 – 2030 (USD Million)
Chapter 6. Application Business Analysis
6.1. Global Plasmid DNA Manufacturing Market: Application Movement Analysis
6.2. DNA Vaccines
6.2.1. DNA Vaccines Market, 2018 – 2030 (USD Million)
6.3. Cell & Gene Therapy
6.3.1. Cell & Gene Therapy Market, 2018 – 2030 (USD Million)
6.4. Immunotherapy
6.4.1. Immunotherapy Market, 2018 – 2030 (USD Million)
6.5. Others
6.5.1. Others Market, 2018 – 2030 (USD Million)
Chapter 7. Disease Business Analysis
7.1. Global Plasmid DNA Manufacturing Market: Disease Movement Analysis
7.2. Infectious Disease
7.2.1. Infectious Disease Market, 2018 – 2030 (USD Million)
7.3. Cancer
7.3.1. Cancer Market, 2018 – 2030 (USD Million)
7.4. Genetic Disorder
7.4.1. Genetic Disorder Market, 2018 – 2030 (USD Million)
7.5. Others
7.5.1. Others Market, 2018 – 2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Global Plasmid DNA Manufacturing Market Share By Region, 2022 & 2030
8.2. North America
8.2.1. North America Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Competitive Scenario
8.2.2.3. Regulatory Framework
8.2.2.4. Target Disease Prevalence
8.2.2.5. U.S. Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Competitive Scenario
8.2.3.3. Regulatory Framework
8.2.3.4. Target Disease Prevalence
8.2.3.5. Canada Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.3. Europe
8.3.1. Europe Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.3.2. Germany
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. Target Disease Prevalence
8.3.2.5. Germany Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.3.3. UK
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. Target Disease Prevalence
8.3.3.5. UK Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. Target Disease Prevalence
8.3.4.5. France Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Competitive Scenario
8.3.5.3. Regulatory Framework
8.3.5.4. Target Disease Prevalence
8.3.5.5. Italy Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Competitive Scenario
8.3.6.3. Regulatory Framework
8.3.6.4. Target Disease Prevalence
8.3.6.5. Spain Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Key Country Dynamics
8.3.7.2. Competitive Scenario
8.3.7.3. Regulatory Framework
8.3.7.4. Target Disease Prevalence
8.3.7.5. Denmark Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Key Country Dynamics
8.3.8.2. Competitive Scenario
8.3.8.3. Regulatory Framework
8.3.8.4. Target Disease Prevalence
8.3.8.5. Sweden Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Competitive Scenario
8.3.9.3. Regulatory Framework
8.3.9.4. Target Disease Prevalence
8.3.9.5. Norway Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. Target Disease Prevalence
8.4.2.5. Japan Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. Target Disease Prevalence
8.4.3.5. China Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. Target Disease Prevalence
8.4.4.5. India Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.4.5. South Korea
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. Target Disease Prevalence
8.4.5.5. South Korea Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.4.6. Australia
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Target Disease Prevalence
8.4.6.5. Australia Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.4.7. Thailand
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. Target Disease Prevalence
8.4.7.5. Thailand Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Target Disease Prevalence
8.5.2.5. Brazil Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.5.3. Mexico
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Target Disease Prevalence
8.5.3.5. Mexico Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.5.4. Argentina
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. Target Disease Prevalence
8.5.4.5. Argentina Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.6. MEA
8.6.1. MEA Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Target Disease Prevalence
8.6.2.5. South Africa Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Target Disease Prevalence
8.6.3.5. Saudi Arabia Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. Target Disease Prevalence
8.6.4.5. UAE Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Target Disease Prevalence
8.6.5.5. Kuwait Plasmid DNA Manufacturing Market, 2018 – 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market/Position Share Analysis, 2022
9.4. Company Profiles/Listing
9.4.1. Charles River Laboratories
9.4.1.1. Overview
9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Danaher
9.4.2.1. Overview
9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. VGXI, Inc.
9.4.3.1. Overview
9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Kaneka Corp.
9.4.4.1. Overview
9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Lonza
9.4.5.1. Overview
9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Nature Technology
9.4.6.1. Overview
9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Cell and Gene Therapy Catapult
9.4.7.1. Overview
9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Eurofins Genomics
9.4.8.1. Overview
9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Luminous BioSciences, LLC
9.4.9.1. Overview
9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Akron Biotech
9.4.10.1. Overview
9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives

List of Tables

Table 1 List Of Secondary Sources
Table 2 List Of Abbreviations
Table 3 Global Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 4 Global Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 5 Global Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 6 Global Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 7 North America Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 8 North America Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 9 North America Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 10 North America Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 11 North America Plasmid DNA Manufacturing Market by Country, 2018 - 2030 (USD Million)
Table 12 U.S. Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 13 U.S. Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 14 U.S. Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 15 U.S. Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 16 Canada Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 17 Canada Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 18 Canada Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 19 Canada Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 20 Europe Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 21 Europe Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 22 Europe Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 23 Europe Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 24 Europe Plasmid DNA Manufacturing Market by Country, 2018 - 2030 (USD Million)
Table 25 UK Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 26 UK Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 27 UK Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 28 UK Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 29 Germany Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 30 Germany Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 31 Germany Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 32 Germany Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 33 France Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 34 France Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 35 France Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 36 France Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 37 Italy Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 38 Italy Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 39 Italy Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 40 Italy Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 41 Spain Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 42 Spain Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 43 Spain Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 44 Spain Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 45 Denmark Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 46 Denmark Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 47 Denmark Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 48 Denmark Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 49 Sweden Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 50 Sweden Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 51 Sweden Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 52 Sweden Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 53 Norway Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 54 Norway Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 55 Norway Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 56 Norway Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 57 Asia Pacific Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 58 Asia Pacific Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 59 Asia Pacific Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 60 Asia Pacific Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 61 Asia Pacific Plasmid DNA Manufacturing Market by Country, 2018 - 2030 (USD Million)
Table 62 China Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 63 China Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 64 China Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 65 China Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 66 Japan Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 67 Japan Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 68 Japan Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 69 Japan Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 70 India Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 71 India Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 72 India Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 73 India Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 74 South Korea Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 75 South Korea Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 76 South Korea Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 77 South Korea Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 78 Australia Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 79 Australia Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 80 Australia Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 81 Australia Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 82 Thailand Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 83 Thailand Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 84 Thailand Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 85 Thailand Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 86 Latin America Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 87 Latin America Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 88 Latin America Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 89 Latin America Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 90 Latin America Plasmid DNA Manufacturing Market by Country, 2018 - 2030 (USD Million)
Table 91 Brazil Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 92 Brazil Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 93 Brazil Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 94 Brazil Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 95 Mexico Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 96 Mexico Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 97 Mexico Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 98 Mexico Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 99 Argentina Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 100 Argentina Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 101 Argentina Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 102 Argentina Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 103 Middle East & Africa Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 105 Middle East & Africa Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 106 Middle East & Africa Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 107 Middle East & Africa Plasmid DNA Manufacturing Market by Country, 2018 - 2030 (USD Million)
Table 108 South Africa Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 109 South Africa Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 110 South Africa Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 111 South Africa Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 112 Saudi Arabia Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 116 UAE Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 117 UAE Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 118 UAE Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD Million)
Table 119 UAE Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 120 Kuwait Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD Million)
Table 121 Kuwait Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD Million)
Table 122 Kuwait Plasmid DNA Manufacturing Market By Application, 2018 - 2030 (USD Million)
Table 123 Kuwait Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD Million)
Table 124 Participant’s Overview
Table 125 Financial Performance
Table 126 Key Companies Undergoing Expansions
Table 127 Key Companies Undergoing Acquisitions
Table 128 Key Companies Undergoing Collaborations
Table 129 Key Companies Launching New Products/Services
Table 130 Key Companies Undergoing Partnerships
Table 131 Key Companies Undertaking Other Strategies

※본 조사보고서 [세계의 플라스미드 DNA 제조 시장 2024-2030 : 질환별 (암, 감염), 등급별 (R&D 등급, GMP 등급), 용도별, 개발 단계별, 지역별] (코드 : GRV24JAN052) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 플라스미드 DNA 제조 시장 2024-2030 : 질환별 (암, 감염), 등급별 (R&D 등급, GMP 등급), 용도별, 개발 단계별, 지역별] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!

세계의 플라스미드 DNA 제조 시장 2024-2030 : 질환별 (암, 감염), 등급별 (…

[이하, 관련 보고서 소개]

세계의 mRNA 합성 재료 시장 (2023~2030) : 캡핑제, 뉴클레오티드, 플라스미드 DNA
GRV23MA023 / Grand View Research / 2023년 1월 / 미국 Grand View Research (그랜드뷰리서치)는 세계의 mRNA 합성 재료 시장 규모가 2023년부터 2030년 사이에 연평균 2.1% 성장하여, 2030년에는 33억 달러에 달할 것으로 전망하고 있습니다. 본 조사 보고서는 세계의 mRNA 합성...mRNA Synthesis Raw Materials Market Growth & Trends The global mRNA synthesis raw materials market size is projected to reach USD 3.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 2.1% from 2023 to 2030....

글로벌 로봇 보조 내시경 시장 (2023-2030) : 병원, 외래 환자 시설
GRV23NOV241 / Grand View Research / 2023년 9월 / 글로벌 로봇 보조 내시경 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 로봇 보조 내시경 시장 규모는 2023년부터 2030년까지 연평균 8. 2%의 성장률을 기록하여 2030년에는 23억 6천만 달러에...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변동, 동향, 범위 Chapter 4. 세계의 로봇 보조 내시경 시장 : 최종 용도별 예측 및 동향 분석 Chapter 5. 세계의 로봇 보조 내시경 시장 : 지역별 예측 및 동향 분석 Chapter 6. 경쟁 현황...

글로벌 수면 모니터링용 피트니스 트래커 시장 (2023-2030) : 스마트 워치, 스마트 밴드
GRV23NOV016 / Grand View Research / 2023년 9월 / 글로벌 수면 모니터링용 피트니스 트래커 시장의 성장과 동향 Grand View Research사의 최신 연구에 따르면, 세계의 수면 모니터링용 피트니스 트래커 시장 규모는 2030년까지 161억 달러에 달할 것으로 예상되며, 2023년부터 2030년까지 연평균...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변수, 동향, 범위 Chapter 4. 세계의 수면 모니터링용 피트니스 트래커 시장 : 제품별 분석 Chapter 5. 세계의 수면 모니터링용 피트니스 트래커 시장 : 유통 채널별 분석 Chapter 6. 세계의 수면 모니터링용 피트니스 트래커 시장 : 지역별 분석 Chapter...

세계의 아데노 수반 바이러스 벡터 제조 시장 (2023~2030) : 임상, 상업
GRV23MR008 / Grand View Research / 2023년 2월 / 미국 Grand View Research (그랜드뷰리서치)의 본 조사 보고서는 세계의 아데노 수반 바이러스 벡터 제조 시장 규모가 2023년부터 2030년 사이에 CAGR 22.5% 증가하여, 2030년에는 39.5억 달러에 달할 것으로 예상하고 있습니다. 본...Adeno Associated Virus Vector Manufacturing Market Growth & Trends The global adeno associated virus vector manufacturing market size is expected to reach USD 3.95 billion by 2030, registering a CAGR of 22.5% over the forecast period, according to a new report by Grand View Research, Inc. This growth is attributed...

글로벌 이상혈색소증 시장 (2023-2030) : 지중해 빈혈, 낫형 세포병, 기타 헤모글로빈 (Hb) 변종
GRV23NOV020 / Grand View Research / 2023년 9월 / 글로벌 이상혈색소증 시장의 성장 및 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 이상혈색소증 시장 규모는 2030년까지 207억 달러에 달할 것으로 예상되며, 2023년부터 2030년까지 12. 6%의 연평균 성장률로 확대될 것으로...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변수/동향/범위 Chapter 4. 세계의 이상혈색소증 시장 : 유형별 분석 Chapter 5. 세계의 이상혈색소증 시장 : 진단별 분석 Chapter 6. 세계의 이상혈색소증 시장 : 치료법별 분석 Chapter 7. 세계의 이상혈색소증 시장 : 지역별 분석 Chapter 8. 경쟁 현황 Chapter...